The pulmonary delivery of insulin may reduce the need for multiple daily subcutaneous injections of insulin for many patients with diabetes. The lungs are an attractive site for delivery of insulin ...
ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...
A Prescription Drug User Fee Act target date of May 29, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License ...
Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...
Of the 416 subjects screened, 335 were randomly assigned to receive treatment and one subject withdrew; therefore, 334 subjects received treatment (of whom 312 were evaluable for efficacy) and 303 ...
ORLANDO -- For type 1 diabetes patients, switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) maintained glycemic control -- for those who used it as intended, the ...
Type 1 diabetes affects about 11% of the population according to the American Diabetes Association. Many people manage the disease using injections or pumps, but a new study that was conducted in part ...
CHICAGO, June 22, 2025 /PRNewswire/ -- Today, a new study demonstrates inhaled insulin as a safe and effective replacement for rapid-acting meal insulin in children with type 1 diabetes. Results from ...
MannKind Corporation announced that it will present data from five studies on inhaled insulin at the 18th International Conference on Advanced Technologies and Treatments for Diabetes in Amsterdam, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Technosphere insulin was tied to improvements in HbA1c ...
What is the effect of using inhaled insulin to address insulin resistance in patients with Alzheimer’s disease? —Catherine Godek, ARNP-C, Tiverton, R.I. While insulin does address elevated plasma ...
Perhaps clashing with our apparently unabashed anti-LIFE sentiment, we present to you word of an inhaled form of insulin, due out within a year. The device would work by using dry powder insulin from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results